Global Medical REIT (NYSE:XRN) Director Charles Fitzgerald Purchases 14,000 Shares of Stock

Global Medical REIT Inc. (NYSE:XRN) Director Charles Fitzgerald purchased 14,000 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The shares were bought at an average cost of $35.78 per share, with a total value of $500,920.00. Following the purchase, the director directly owned 138,893 shares of the company’s stock, valued at approximately $4,969,591.54. This represents a 11.21% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.

Charles Fitzgerald also recently made the following trade(s):

• On Monday, August 10th, Charles Fitzgerald acquired 27,600 shares of Global Medical REIT stock. The stock was purchased at an average cost of $35.94 per share, for a total transaction of $991,944.00.

Global Medical REIT Trading Up 0.7%

XRN opened at $36.52 on Friday. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 1.68. The stock’s fifty day moving average is $36.59 and its two-hundred day moving average is $35.80. The company has a market capitalization of $483.43 million, a P/E ratio of 9.82 and a beta of 1.09. Global Medical REIT Inc. has a 52 week low of $29.05 and a 52 week high of $39.93.

Global Medical REIT (NYSE:XRN) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $4.78 EPS for the quarter, beating the consensus estimate of $0.83 by $3.95. Global Medical REIT had a return on equity of 13.74% and a net margin of 36.82%.The firm had revenue of $39.75 million for the quarter. Analysts forecast that Global Medical REIT Inc. will post 3.06 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on XRN. BMO Capital Markets increased their price objective on shares of Global Medical REIT from $39.00 to $40.00 and gave the company a “market perform” rating in a research note on Monday, July 13th. Zacks Research raised shares of Global Medical REIT to a “hold” rating in a research note on Wednesday, July 22nd. Citizens Jmp upped their target price on Global Medical REIT from $40.00 to $42.00 and gave the stock a “market outperform” rating in a report on Tuesday, May 26th. Raymond James Financial initiated coverage on Global Medical REIT in a report on Wednesday, June 17th. They set a “market perform” rating for the company. Finally, Weiss Ratings cut Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, July 30th. Two research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $40.25.

Hedge Funds Weigh In On Global Medical REIT

A number of large investors have recently added to or reduced their stakes in the company. Invesco Ltd. boosted its holdings in shares of Global Medical REIT by 4.2% in the 4th quarter. Invesco Ltd. now owns 310,432 shares of the company’s stock valued at $10,474,000 after buying an additional 12,471 shares in the last quarter. Mackenzie Financial Corp bought a new position in shares of Global Medical REIT during the 4th quarter worth approximately $563,000. XTX Topco Ltd bought a new position in shares of Global Medical REIT during the 4th quarter worth approximately $515,000. Tudor Investment Corp ET AL purchased a new stake in Global Medical REIT during the fourth quarter valued at approximately $930,000. Finally, Clifford Capital Partners LLC lifted its position in Global Medical REIT by 31.3% during the fourth quarter. Clifford Capital Partners LLC now owns 14,694 shares of the company’s stock valued at $496,000 after acquiring an additional 3,504 shares during the last quarter. 57.52% of the stock is currently owned by institutional investors.

Trending Headlines about Global Medical REIT

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: Insiders purchased roughly $2.54 million of shares over August 10–12. CEO Mark Okey Decker, Jr. bought 15,425 shares in three transactions, COO Aaron Robert Roseth acquired 13,500 shares for approximately $495,855, and director Charles Fitzgerald purchased 41,600 shares worth about $1.49 million. The purchases increase management’s financial exposure to the company and may signal confidence in its outlook. SEC insider purchase filing
• Positive Sentiment: The company’s latest quarterly results were substantially above expectations, with earnings per share of $4.78 versus the $0.83 analyst consensus and revenue of $39.75 million. Global Medical REIT also reported a 36.82% net margin and 13.74% return on equity, providing fundamental support for the recent interest in the shares.
• Neutral Sentiment: Analyst sentiment remains mixed. The consensus rating is “Hold,” with two Buy, five Hold and one Sell rating; however, the average price target of $40.25 is above the stock’s recent trading range. Price targets include $42 from Citizens JMP and $38 from Compass Point.
• Neutral Sentiment: A recent article discusses the company’s transition and rebranding to Chiron Real Estate, which could affect how investors interpret the company’s identity and strategy. How Did Chiron Real Estate Emerge From the GMRE Rebrand?
• Negative Sentiment: Global Medical REIT carries elevated leverage, with a debt-to-equity ratio of 1.68, while its quick and current ratios are both 0.68. These figures could limit financial flexibility, particularly if interest rates remain high or property markets weaken.

About Global Medical REIT

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.